SLAB Narrows Losses, Revenue Jumps 24% Amid Strong Operating Cash Flow

TL;DR

**SLAB is showing strong signs of a turnaround with surging revenue and positive operating cash flow, making it a compelling buy for growth-oriented investors.**

AI Summary

SILICON LABORATORIES INC. (SLAB) reported a net loss of $9.936 million for the three months ended October 4, 2025, a significant improvement from the $28.504 million net loss in the same period of 2024. Revenues increased substantially to $205.999 million for the quarter, up from $166.395 million year-over-year, representing a 23.8% increase. For the nine months ended October 4, 2025, the company's net loss was $62.223 million, a considerable reduction from $167.187 million in the prior year. Total assets grew to $1.253 billion as of October 4, 2025, from $1.223 billion at December 28, 2024, driven by an increase in cash and cash equivalents to $341.403 million from $281.607 million. Operating expenses rose to $131.361 million for the quarter, up from $120.021 million, primarily due to increased research and development and selling, general, and administrative costs. The company's inventory decreased to $82.190 million from $105.639 million, indicating improved inventory management. Despite the net loss, the company generated $87.358 million in net cash from operating activities for the nine months ended October 4, 2025, a positive reversal from the $24.039 million cash used in operating activities in the prior year.

Why It Matters

SLAB's significant revenue growth and improved net loss figures indicate a potential turnaround, which is crucial for investors looking for signs of recovery in the semiconductor sector. The positive shift to $87.358 million in operating cash flow from a negative $24.039 million year-over-year suggests better operational efficiency and financial health, potentially attracting new investors. For employees, this could signal greater job security and future growth opportunities. In a competitive market, SLAB's ability to increase revenue by 23.8% while reducing losses demonstrates its resilience and competitive positioning, potentially impacting customer confidence and market share.

Risk Assessment

Risk Level: medium — Despite improved financial metrics, SILICON LABORATORIES INC. reported a net loss of $9.936 million for the quarter and $62.223 million for the nine months ended October 4, 2025, indicating continued unprofitability. The company also faces ongoing risks related to its significant operating expenses, which totaled $131.361 million for the quarter, and the potential for actual results to differ materially from forward-looking statements as highlighted in the 'Cautionary Statement'.

Analyst Insight

Investors should consider initiating a position in SLAB, given the substantial revenue growth of 23.8% and the significant improvement in net loss. The positive shift to $87.358 million in operating cash flow for the nine-month period suggests a strengthening financial position, warranting further due diligence into future growth catalysts and profitability projections.

Financial Highlights

debt To Equity

0.17

revenue

$576.558M

operating Margin

-11.66%

total Assets

$1.253B

total Debt

$31.311M

net Income

($62.223M)

eps

($1.91)

gross Margin

56.34%

cash Position

$341.403M

revenue Growth

+38.1%

Key Numbers

• $205.999M — Quarterly Revenue (Up 23.8% from $166.395M in Q3 2024)
• ($9.936M) — Quarterly Net Loss (Improved from ($28.504M) in Q3 2024)
• $576.558M — Nine-Month Revenue (Up from $418.137M in prior nine-month period)
• ($62.223M) — Nine-Month Net Loss (Improved from ($167.187M) in prior nine-month period)
• $87.358M — Nine-Month Operating Cash Flow (Positive, compared to ($24.039M) cash used in prior nine-month period)
• $341.403M — Cash and Cash Equivalents (Increased from $281.607M at December 28, 2024)
• $82.190M — Inventories (Decreased from $105.639M at December 28, 2024)
• $131.361M — Quarterly Operating Expenses (Increased from $120.021M in Q3 2024)
• ($0.30) — Basic Loss Per Share (Quarterly) (Improved from ($0.88) in Q3 2024)
• 32,852,942 — Shares Outstanding (As of October 28, 2025)

Key Players & Entities

• SILICON LABORATORIES INC. (company) — registrant
• SEC (regulator) — Securities and Exchange Commission
• FASB (regulator) — Financial Accounting Standards Board
• $205.999 million (dollar_amount) — revenues for three months ended October 4, 2025
• $166.395 million (dollar_amount) — revenues for three months ended September 28, 2024
• $9.936 million (dollar_amount) — net loss for three months ended October 4, 2025
• $28.504 million (dollar_amount) — net loss for three months ended September 28, 2024
• $62.223 million (dollar_amount) — net loss for nine months ended October 4, 2025
• $167.187 million (dollar_amount) — net loss for nine months ended September 28, 2024
• $87.358 million (dollar_amount) — net cash provided by operating activities for nine months ended October 4, 2025

FAQ

Risk Factors

• Competition and Market Acceptance [high — market]: The company faces intense competition from numerous companies, some with greater financial resources. Failure to achieve market acceptance for new products or to compete effectively on price, performance, and features could materially impact revenue and profitability. The report does not specify competitors but highlights the dynamic nature of the semiconductor market.
• Supply Chain and Manufacturing Disruptions [medium — operational]: The company relies on third-party manufacturers and suppliers. Disruptions in the supply chain, including shortages of components or manufacturing capacity, could lead to production delays and impact the ability to meet customer demand. This is a common risk in the semiconductor industry.
• Fluctuations in Foreign Currency Exchange Rates [low — financial]: As a global company, SLAB is exposed to foreign currency exchange rate fluctuations, which can affect reported revenues and expenses. While the company does not disclose specific hedging strategies, significant adverse movements could impact financial results.
• Compliance with Export Controls and Trade Regulations [medium — regulatory]: The company's products are subject to U.S. and foreign export control laws and regulations. Non-compliance could result in significant penalties, including fines and restrictions on business operations. The evolving geopolitical landscape adds complexity to these regulations.
• Intellectual Property Protection [medium — operational]: Protecting intellectual property is critical. The company may face challenges in defending its patents and proprietary technologies against infringement, and litigation could be costly and divert management attention. Conversely, the company could be subject to claims of infringing on others' intellectual property.
• Economic Downturns [medium — financial]: Global economic conditions can significantly impact demand for the company's products, particularly in the consumer electronics and automotive sectors. A prolonged economic downturn could lead to reduced sales and profitability.

Industry Context

Silicon Laboratories operates in the highly competitive semiconductor industry, characterized by rapid technological advancements and cyclical demand. The company focuses on Internet of Things (IoT) connectivity, wireless technologies, and infrastructure solutions. Key trends include the increasing demand for connected devices, the expansion of 5G networks, and the growing complexity of embedded systems, all of which present opportunities and challenges for SLAB.

Regulatory Implications

SLAB is subject to various regulations, including U.S. export control laws and international trade regulations, which can impact its global operations and sales. Compliance with these evolving regulations is critical to avoid penalties and maintain market access. Additionally, data privacy regulations in different jurisdictions could affect the development and deployment of IoT solutions.

What Investors Should Do

1. Monitor the company's progress in converting revenue growth into sustained profitability, given the continued net loss.
2. Analyze the drivers behind the increase in operating expenses, particularly R&D and SG&A, to assess efficiency and future growth investments.
3. Evaluate the company's inventory management improvements and their impact on working capital and cash flow generation.
4. Assess the company's competitive positioning and market share within its key product segments, especially in the rapidly evolving IoT market.
5. Review the company's cash position and operating cash flow generation as key indicators of financial health and ability to fund operations and growth.

Key Dates

• 2025-10-04: End of Third Quarter 2025 — Reporting period for the 10-Q, showing improved revenue and reduced net loss compared to the prior year.
• 2024-09-28: End of Third Quarter 2024 — Prior year comparison period, highlighting the significant improvement in financial performance for Q3 2025.
• 2025-12-28: End of Fiscal Year 2024 — Balance sheet comparison date, showing an increase in total assets and cash reserves.

Glossary

Accumulated other comprehensive income

Represents unrealized gains and losses that are not included in net income but are reported in a separate section of the income statement. For SLAB, this is a small positive amount. (Part of stockholders' equity, it reflects items like foreign currency translation adjustments that impact the overall equity but not the net income directly.)

Deferred revenue

Revenue that has been received by the company but not yet earned, as the goods or services have not been delivered or performed. SLAB shows an increase in this liability. (An increase suggests the company has received payments for future services or product deliveries, which could indicate future revenue streams.)

Goodwill

An intangible asset that arises when one company acquires another for a price greater than the fair market value of its identifiable net assets. SLAB's goodwill remains constant at $376.389M. (Represents the value of acquired businesses and is a significant portion of SLAB's assets, indicating past acquisitions.)

Provision for income taxes

The amount of tax expense recognized by a company for a given period. SLAB shows a provision for income taxes in the current period, contrasting with a larger provision in the prior year's loss. (While the company reported a net loss, it still has tax implications, potentially related to foreign operations or deferred tax assets/liabilities.)

Weighted-average common shares outstanding

The average number of shares of common stock outstanding during a period, used to calculate earnings per share. SLAB's shares outstanding have increased slightly. (Crucial for calculating EPS, an increase in shares can dilute EPS if net income does not grow proportionally.)

Year-Over-Year Comparison

Compared to the prior year's comparable period, Silicon Laboratories Inc. (SLAB) has demonstrated significant financial improvement. Revenue for the nine months ended October 4, 2025, surged by 38.1% to $576.558 million from $418.137 million. This top-line growth has contributed to a substantial reduction in net loss, which decreased from $167.187 million to $62.223 million over the same period. Furthermore, the company has reversed its operating cash flow trend, generating $87.358 million compared to using $24.039 million in the prior year, indicating improved operational efficiency and cash management.

Key Financial Figures

• $0.0001 — ge on which registered Common Stock, $0.0001 par value SLAB The NASDAQ Stock Market

Filing Documents

• slab-20251004.htm (10-Q) — 1016KB
• slab-20251004xexx311.htm (EX-31.1) — 10KB
• slab-20251004xexx312.htm (EX-31.2) — 10KB
• slab-20251004xexx321.htm (EX-32.1) — 5KB
• 0001038074-25-000023.txt ( ) — 5059KB
• slab-20251004.xsd (EX-101.SCH) — 26KB
• slab-20251004_cal.xml (EX-101.CAL) — 69KB
• slab-20251004_def.xml (EX-101.DEF) — 97KB
• slab-20251004_lab.xml (EX-101.LAB) — 442KB
• slab-20251004_pre.xml (EX-101.PRE) — 276KB
• slab-20251004_htm.xml (XML) — 702KB

Financial Information

Part I. Financial Information Page Number Item 1.

Financial Statements (Unaudited)

Financial Statements (Unaudited): Condensed Consolidated Balance Sheets at October 4, 2025 and December 28, 2024 3 Condensed Consolidated Statements of Operations for the three and nine months ended October 4, 2025 and September 28, 2024 4 Condensed Consolidated Statements of Comprehensive Loss for the three and nine months ended October 4, 2025 and September 28, 2024 5 Condensed Consolidated Statements of Changes in Stockholders' Equity for the three and nine months ended October 4, 2025 and September 28, 2024 6 Condensed Consolidated Statements of Cash Flows for the nine months ended October 4, 2025 and September 28, 2024 7 Notes to Condensed Consolidated Financial Statements 8 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 18 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 24 Item 4.

Controls and Procedures

Controls and Procedures 24

Other Information

Part II. Other Information Item 1.

Legal Proceedings

Legal Proceedings 24 Item 1A.

Risk Factors

Risk Factors 25 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 39 Item 3. Defaults Upon Senior Securities 39 Item 4. Mine Safety Disclosures 40 Item 5. Other Information 40 Item 6. Exhibits 41 Cautionary Statement Except for the historical financial information contained herein, the matters discussed in this report on Form 10-Q (as well as documents incorporated herein by reference) may be considered "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include declarations regarding the intent, belief or current expectations of Silicon Laboratories Inc. and its management and may be signified by the words "believe," "estimate," "expect," "intend," "anticipate," "plan," "project," "will" or similar language. You are cautioned that any such forward-looking statements are not guarantees of future performance and involve a number of risks and uncertainties. Actual results could differ materially from those indicated by such forward-looking statements. Factors that could cause or contribute to such differences include those discussed under "Risk Factors" and elsewhere in this report. Silicon Laboratories disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. 2 Table of Contents

Financial Information

Part I. Financial Information

Financial Statements

Item 1. Financial Statements Silicon Laboratories Inc. Condensed Consolidated Balance Sheets (In thousands, except per share data) (Unaudited) October 4, 2025 December 28, 2024 Assets Current assets: Cash and cash equivalents $ 341,403 $ 281,607 Short-term investments 97,622 100,554 Accounts receivable, net 67,308 54,479 Inventories 82,190 105,639 Prepaid expenses and other current assets 64,036 59,754 Total current assets 652,559 602,033 Property and equipment, net 128,323 132,136 Goodwill 376,389 376,389 Other intangible assets, net 25,425 36,499 Other assets, net 70,371 75,617 Total assets $ 1,253,067 $ 1,222,674 Liabilities and Stockholders' Equity Current liabilities: Accounts payable $ 55,647 $ 42,448 Deferred revenue and returns liability 8,447 3,073 Other current liabilities 81,216 52,362 Total current liabilities 145,310 97,883 Other non-current liabilities 37,044 44,770 Total liabilities 182,354 142,653 Commitments and contingencies Stockholders' equity: Preferred stock – $ 0.0001 par value; 10,000 shares authorized; no shares issued — — Common stock – $ 0.0001 par value; 250,000 shares authorized; 32,853 and 32,458 shares issued and outstanding at October 4, 2025 and December 28, 2024, respectively 3 3 Additional paid-in capital 130,979 78,227 Retained earnings 939,498 1,001,721 Accumulated other comprehensive income 233 70 Total stockholders' equity 1,070,713 1,080,021 Total liabilities and stockholders' equity $ 1,253,067 $ 1,222,674 The accompanying notes are an integral part of these Condensed Consolidated Financial Statements. 3 Table of Contents Silicon Laboratories Inc. Condensed Consolidated Statements of Operations (In thousands, except per share data) (Unaudited) Three Months Ended Nine Months Ended October 4, 2025 September 28, 2024 October 4, 2025 September 28, 2024 Revenues $ 205,999 $ 166,395 $ 576,558 $ 418,137 Cost of revenues 86,980 76,082 251,653 196,172 Gross profit 119,019 90,313

View Full Filing

View this 10-Q filing on SEC EDGAR